Gynecologic Oncology | Kathleen Moore, MD

Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer — Faculty Presentation 2: Integration of PARP Inhibitor Maintenance Therapy into the Management of Newly Diagnosed OC — Dr Moore CME information and select publications